Home|Journals|Articles by Year

Directory for Medical Articles
 

Review Article

SRP. 2011; 2(1): 37-42


Therapeutic Applications of Monoclonal Antibodies

Prajapati DS, Shah JS, Dave JB, Patel CN.


Abstract

Monoclonal antibodies drive the development of multibillion dollar biotechnology industry. Many
of the pharmaceuticals companies have entered monoclonal antibodies sector, attracted by quicker
and less costly development, higher success rates, premium pricing, and potentially reduced
threats from generics. The ideal treatment of rheumatoid arthritis (RA) should be safe, produce
sustained disease remission and stop radiological damage after a brief course of treatment. If
repeated treatments are necessary, they must be safe and economical to use in the long term. It
is against these criteria that new treatments for RA, including mAb, should and will be assessed.
Monoclonal antibodies are used in the treatment of cancer, including leukemia, colorectal cancer,
breast cancer and non-Hodgkin’s lymphoma, RA, ischemic heart disease and transplant rejection.

Key words: Breast cancer, Leukemia, Monoclonal antibody, Rheumatoid arthritis






Full-text options


Share this Article



Online Article Submission
• ejmanager.com







eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.